摘要
目的探讨认知治疗对精神分裂症患者服药依从性和复发的影响。方法将106例精神分裂症患者随机分为研究组(54例)和对照组(52例),两组均进行系统的抗精神病药物治疗和一般的健康教育,研究组在此基础上进行认知心理治疗。并于入院前、出院时、出院后6个月、出院后1a分别用简明精神病评定量表(BPRS)、自知力与治疗态度问卷量表(ITAQ)及自编服药依从性调查量表评定。结果两组患者入院前BPRS、ITAQ、服药依从性评分差别无统计学意义(P>0.05),出院时、出院后6个月、出院后1a差别均有统计学意义(出院时t值分别为5.72,3.37,5.10;出院后6个月t值分别为5.27,5.13,5.89;出院后1at值分别为4.28,4.53,5.28;均P<0.01)。两组患者在出院后6个月、出院后1a的复发率差别亦均有统计学意义,研究组患者复发率低于对照组(χ2值分别为4.23和6.79,均P<0.05)。结论在系统的抗精神病药物治疗和一般健康教育基础上进行认知治疗,能够提高精神分裂症患者治疗依从性,降低复发率。
Objective To study the effect of cognitive treatment on the compliance for medication and recrudescence of patients with schizophrenia.Method 106 schizophrenic patients were randomly allocated to the study and the control; both groups treated with antipsyehotic medical treatment and health education, while the study group also accepted cognitive psychotherapy. Before treatment and at the ends of 0, 6, 12 months of treatment, the efficacy were investigated using the Brief Psychiatric Rating Scale （BPRS）, Insight and Treatment Attitude Questionnaire （ITAQ） and Self-designed Compliance Survey in order to assess the compliance and the recrudescence. Results All the indexes after cognitive psychotherapy were significantly better than those before cognitive psychotherapy. Conclusion The cognitive psychotherapy can effectively reinforce the compliance of patients with schizophrenia, and then improve the quality of life for them.
出处
《中国慢性病预防与控制》
CAS
2008年第1期41-42,共2页
Chinese Journal of Prevention and Control of Chronic Diseases
